Bradley Foster & Sargent’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-44,845
Closed -$479K 541
2025
Q3
$479K Buy
44,845
+16,182
+56% +$159K 0.01% 395
2025
Q2
$277K Buy
+28,663
New +$296K ﹤0.01% 471
2022
Q3
Sell
-6,406
Closed -$216K 433
2022
Q2
$216K Sell
6,406
-762
-11% -$26.7K 0.01% 420
2022
Q1
$250K Sell
7,168
-279
-4% -$9.54K 0.01% 425
2021
Q4
$227K Sell
7,447
-616
-8% -$20.1K ﹤0.01% 422
2021
Q3
$264K Sell
8,063
-6,383
-44% -$204K 0.01% 373
2021
Q2
$437K Buy
+14,446
New +$476K 0.01% 322

Other funds holding OGN

Bradley Foster & Sargent's OGN Position: Q4 2025 in Review

Bradley Foster & Sargent sold out of Organon & Co (OGN) in Q4 2025, closing a stake of 44,845 shares — an estimated $479K sold.

Bradley Foster & Sargent first reported a position in OGN in Q2 2021 and held it in 7 quarters. The position peaked at $479K in Q3 2025. 634 funds tracked by Wall St. Rank hold OGN as of Q4 2025.

  • Bradley Foster & Sargent reported no remaining Organon & Co position as of Q4 2025 after selling out during the quarter.
  • Bradley Foster & Sargent sold 44,845 Organon & Co shares in Q4 2025, an estimated $479K.
  • Bradley Foster & Sargent first reported a position in Organon & Co in Q2 2021 and held it in 7 quarters.
  • Bradley Foster & Sargent's Organon & Co position peaked at $479K in Q3 2025.
  • 634 funds tracked by Wall St. Rank held Organon & Co as of Q4 2025.

Based on Bradley Foster & Sargent's 13F filing for Q4 2025, filed 12 Feb 2026.